Trial Profile

A Phase 1, Randomized, Blinded, Placebo-Controlled, Single and Multiple Dose Escalation and Food Effect Study of ABI-H3733 in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 29 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ABI-H3733 (Primary)
Indications Hepatitis B
Focus Adverse reactions
Sponsors Assembly Biosciences

Most Recent Events

12 Nov 2021 According to an Assembly Biosciences media release, data from this study will be presented at the upcoming American Association for the Study of Liver Diseases (AASLD), The Liver Meeting
12 Nov 2021 Results published in Assembly Biosciences Media Release.
01 Nov 2021 According to an Assembly Biosciences media release, data from this study will be presented at the upcoming American Association for the Study of Liver Diseases (AASLD), The Liver Meeting

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com